Vancomycin Heteroresistance and Methicillin-ResistantStaphylococcus aureus
Open Access
- 1 March 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 199 (5) , 605-609
- https://doi.org/10.1086/596630
Abstract
Heteroresistance refers to the presence, within a larger population of fully antimicrobial-susceptible microorganisms, of subpopulations with lesser susceptibility. This phenomenon has been described in a wide range of microorganisms, but much recent attention has been directed toward its expression in Staphylococcus aureus . Although it has long been known that resistance to methicillin is characteristically heterogeneously expressed by this organism [ 1 ], the current focus revolves around its heteroresistance to vancomycin. Heteroresistant subpopulations of vancomycin-susceptible S. aureus (hVISA) were first described in 1997 [ 2 ], shortly after the initial description of vancomycin intermediately susceptible strains (VISA) [ 3 ]. hVISA have minimum inhibitory concentrations (MICs) in the intermediately susceptible range and likely represent a step on the path to the development of a fully VISA populationKeywords
This publication has 46 references indexed in Scilit:
- Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007)Journal of Clinical Microbiology, 2008
- Associations between the Genotypes of Staphylococcus aureus Bloodstream Isolates and Clinical Characteristics and Outcomes of Bacteremic PatientsJournal of Clinical Microbiology, 2008
- Evaluation of a New Etest Vancomycin-Teicoplanin Strip for Detection of Glycopeptide-Intermediate Staphylococcus aureus (GISA), in Particular, Heterogeneous GISAJournal of Clinical Microbiology, 2008
- The Rationale for Revising the Clinical and Laboratory Standards Institute Vancomycin Minimal Inhibitory Concentration Interpretive Criteria for Staphylococcus aureusClinical Infectious Diseases, 2007
- Unstable Vancomycin Heteroresistance Is Common among Clinical Isolates of Methiciliin-Resistant Staphylococcus aureusJournal of Clinical Microbiology, 2005
- Alterations of Cell Wall Structure and MetabolismAccompany Reduced Susceptibility to Vancomycin in an IsogenicSeries of Clinical Isolates of StaphylococcusaureusJournal of Bacteriology, 2003
- Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic MethodsAntimicrobial Agents and Chemotherapy, 2003
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1994